The stock of Westlake Village biopharmaceutical firm MannKind Corp. hit its highest share price in more than a year after the company announced early this month that it had updated the Food and Drug Administration label of its only product. Share prices rose more than 152 percent in the eight trading days following the announcement, closing at $5...

Subscribe to get the full story.


Are you a subscriber? Sign In